Jessica Williams, DO
Family Medicine · Willow Park, TXNPI 1649533944
Payments from drug & device makers
Across 208 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$714
- AbbVie$456
- Lilly USA, LLC$228
- Pfizer$202
- Boehringer Ingelheim$190
- TG Therapeutics, Inc.$174
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,276100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $714 |
| AbbVie(2 entities) | 27 | $456 |
| Lilly USA, LLC | 16 | $228 |
| Pfizer | 19 | $202 |
| Boehringer Ingelheim | 9 | $190 |
| TG Therapeutics, Inc. | 5 | $174 |
| Abbott | 8 | $161 |
| AstraZeneca | 10 | $155 |
| Sanofi-aventis U.S. LLC | 8 | $122 |
| GSK | 7 | $110 |
| Merck | 6 | $83 |
| Amgen | 5 | $79 |
| Exact Sciences | 4 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Amarin Pharma, Inc. | 3 | $50 |
| Bayer | 3 | $43 |
| Johnson & Johnson | 3 | $40 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| Nalpropion Pharmaceuticals LLC | 3 | $35 |
| Biogen | 2 | $35 |
| Ironshore Pharmaceuticals Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $29 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Cranial Technologies, Inc | 1 | $15 |
| Circassia Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Upsher-smith Laboratories LLC | 1 | $12 |
| VBI Vaccine (delaware) Inc. | 1 | $12 |
| Nabriva Therapeutics, PLC | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
| Mylan Specialty L.p. | 1 | $11 |
How this compares
$3,276 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 64 | $108,491 |
| MounjaroTirzepatide | 56 | $96,355 |
| JardianceEmpagliflozin | 26 | $46,762 |
| XareltoRivaroxaban | 26 | $30,546 |
| JanuviaSitagliptin Phosphate | 12 | $19,382 |
| FarxigaDapagliflozin Propanediol | 13 | $10,700 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $6,071 |
| Levothyroxine Sodium | 309 | $3,275 |
| Gabapentin | 102 | $2,786 |
| Levemir FlexpenInsulin Detemir | 17 | $2,751 |
| Atorvastatin Calcium | 249 | $2,548 |
| Losartan Potassium | 190 | $1,880 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 79 | $1,827 |
| Bupropion XlBupropion Hcl | 50 | $1,621 |
| Omeprazole | 100 | $1,602 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $714 | $108,49164 claims |
| Lilly USA, LLCMounjaro | $228 | $96,35556 claims |
| Boehringer IngelheimJardiance | $190 | $46,76226 claims |
| Johnson & JohnsonXarelto | $40 | $30,54626 claims |
| MerckJanuvia | $83 | $19,38212 claims |
| AstraZenecaFarxiga | $155 | $10,70013 claims |
| GSKBreo Ellipta | $110 | $6,07113 claims |
| AbbVieArmour Thyroid, Synthroid | $456 | $2,57344 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Willow Park
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.